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Abstract
Background: There are various parameters to analyze obesity, however, no standard reference to predict, screen or
diagnose PCOS with various obesity parameters has been established, and the accuracy of these parameters still
needs to be studied.This study was to use the receiver operating characteristic (ROC) curve to explore the different
values of three obesity parameters, body mass index (BMI), waist circumference (WC) and percentage of body fat
(PBF) in the diagnosis of polycystic ovary syndrome (PCOS) in Chinese childbearing women.
Methods: Three hundred patients who were diagnosed with PCOS at Center of Reproductive Medicine and
Genetics of Peking University First Hospital were enrolled in this study, and 110 healthy age-matched women were
enrolled as controls. The characteristics of BMI, WC and PBF in PCOS patients were analyzed.
Results: Compared with the control group, all the three obesity parameters were significantly increased in PCOS
group. In terms of ROC area under the curve, WC > PBF > BMI, and they were all significantly different from those of
the control. At a cut-off point of 80.5 cm, WC has a sensitivity of 73.6 % and a specificity of 85 % in diagnosis of
PCOS; At a cut-off point of 29 %, PBF has a sensitivity of 88.2 % and a specificity of 57.7 % in diagnosis of PCOS;
and at a cut-off point of 26.6 kg/m2, BMI has a sensitivity of 54.5 % and a specificity of 98 % in diagnosis of PCOS.
Conclusion: WC, BMI and PBF are valuable in screening and diagnosis of PCOS in Chinese childbearing women.
PBF can be used to screen PCOS as it has a better sensitivity, while BMI can be used in the diagnosis of PCOS as it
has a better specificity.
Keywords: Childbearing age, Polycystic ovary syndrome, Obesity, Body mass index, Waist circumference,
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Abbreviations: ROC, the receiver operating characteristic; BMI, body mass index; WC, waist circumference;
PBF, percentage of body fat; PCOS, polycystic ovary syndrome; LH, luteinizing hormone; ASRM, the American
Society for Reproductive Medicine; SHBG, sex hormone-binding globulin; WHO, World Health Organization;
IDF, the International Diabetes Federation
* Correspondence: xuyangm@126.com; guoxh@medmail.com.cn
2Center of Reproduction and Genetics, Peking University First Hospital,
Beijing, China
4Department of Endocrinology, Peking University First Hospital, Beijing, China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dou et al. Journal of Ovarian Research  (2016) 9:51 
DOI 10.1186/s13048-016-0260-9
Background
Polycystic ovary syndrome (PCOS) was first reported by
Stein and Leventhal [1] in 1935, so it is also called Stein-
Leventhal syndrome. It is the most common female
endocrine and metabolic disorder, and its incidence rate
is about 5.6 % among women aged 19–45 years old in
China [2]. PCOS is a complex disease with high clinical
heterogeneity, excess androgen production and elevated
serum luteinizing hormone (LH) are its serological fea-
tures. It is a major cause of infertility in women. Studies
from different countries have shown that the comorbidity
rate of obesity in patients with PCOS was 30–70 % [3, 4].
The reproductive, endocrinological and metabolic disorders
(except hirsutism) in obese PCOS patients are more severe
than non-obese patients, and the long-term risk of the inci-
dence of metabolic syndrome, type 2 diabetes mellitus
(DM), cardiovascular disease (CVD) as well as breast can-
cer, endometrial cancer and other complications was also
increased exponentially [5]. There are various parameters
to analyze obesity, however, no standard reference to
predict, screen or diagnose PCOS with various obesity
parameters has been established, and the accuracy of
these parameters still needs to be studied. This study
was designed based on the Rotterdam PCOS consensus
criteria, to explore the accuracy and best cut-off points
of three obesity parameter, i.e., body mass index (BMI),
waist circumference (WC) and percentage of body fat
(PBF), in PCOS diagnosis, as well as to compare their
sensitivity and specificity to provide basis for rational
application of obesity parameters in prediction, screen
and diagnosis of PCOS among high-risk populations.
Methods
Study subjects
Three hundred study subjects who were diagnosed with
PCOS at Reproduction and Genetic Center of Peking
University First Hospital from June 2015 to January
2016 were selected. Patients were did not take any hor-
mone medication within the past 3 months. 110 healthy
women of childbearing age who have normal menstru-
ation period and biphasic basal body temperature were
selected as normal control. The ages of the two groups
were matched to each other. This study was approved by
the Ethics Committee of China Registered Clinical Trial
and all the study subject have signed informed consent to
voluntarily participate the study.
PCOS diagnostic criteria
Based on the American Society for Reproductive Medicine
(ASRM) Rotterdam Revised Diagnostic Criteria, a patient
can be with diagnosed as PCOS if two of the following
three criteria are met: (1) no ovulation or irregular ovula-
tion; (2) clinical (such as hirsutism, acne) or biochemical
evidence associated with elevated androgen levels; (3)
enlarged ovaries, each side has 12 or more small follicles
with a diameter of at least 2 ~ 9 mm; plus exclusion of
hyperlactatemia and other metabolic diseases that produce
high-level of androgen such as Cushing’s syndrome, con-
genital adrenal hyperplasia, ovarian or adrenal tumors.
Anthropometric measurements
Measurements were carried out in the hospital’s outpatient
clinic, performed by the same observer in accordance with
the provisions of WHO. For measurement of height (m),
the examinee was required to be barefoot, the rear point of
the feet, hip and the rear point of head were on the same
vertical line, the measurement value was approximated to
the nearest 0.5 cm; for measurement of body weight (kg),
electronic scale was used, and the examinee was required
to be fasted overnight and urine and stool were emptied,
only underwear was allowed, the measurement values was
approximated to the nearest 100 g, BMI was calculated
with the formula: weight (kg)/(height)2 (m2); for measure-
ment of waist circumference, the examinee was required to
stand upright with two feet apart 25 ~ 30 cm, so that the
weight is evenly distributed on both legs, the waist circum-
ference was measured in a horizontal level through the
midpoint that links the iliac crest and the lower margin of
the 12th rib (the measurement tape was placed close to the
skin, but cannot repress the soft tissue), the measurement
values was approximated to the nearest 1 mm.
Body composition measurement
The body composition of the two groups was measured
using bioelectrical impedance body composition analyzer
(Multi-frequency bioelectrical impedance analyzer NQA-
PI). On the test day, the examinee was asked to minimize
eating and drinking, no tense activity was allowed within
6 h before the test to avoid its affection on body compos-
ition measurements. During measurement, the examinee
was asked to take off socks, standing on the test bench with
the body relaxed, with both feet on the foot electrodes and
both hands holding firmly on the hand electrodes, then
basal metabolic rate, total water, the amount of non-fat
tissue, muscle mass, body fat mass, and percentage of
body fat (PBF) were measured.
Statistical analysis
SAS 9.3 software was used in statistical analysis. 1).
Measurement data were shown as x  s; independent
sample t test or Wilcoxon test was used to compare dif-
ference between the two groups, P <0.05 was considered
statistically significant; 2). Receiver operating characteristic
curve (ROC curve) was drawn using Mann-Whitney
method, and area under the ROC curve (area under
curve, AUC) and Somers’ D were used to determine
the overall accuracy of each predictor (area under the
curve ≥0.5 was considered to have diagnostic value,
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the larger the area, the larger the value); the optimal
cut-off points for BMI, WC, PBF to predict PCOS was
determined according to Youden index maximum points;
3). The cut-off point where the sensitivity reaches 90 % was
determined as the reference standard for screening PCOS
with BMI, WC and PBF; 4). The cut-off point where the
specificity reaches 90 % was determined as the reference
standard for diagnosis of PCOS with BMI, WC and PBF.
Results
Comparison of Age, BMI, WC and PBF between the two
groups
Comparison was performed using independent samples t
test or Wilcoxon test. The ages of the PCOS group were
between 16 to 40 years with mean 28.55 ± 4.27 years; the
ages of control group were between 23 to 38 years with
mean 28.53 ± 3.26 years. There was no significant differ-
ence between the two groups (Table 1). As shown in
Table 1 and Fig. 1, compared with the healthy control
group, all three parameters, WC (89.67 ± 13.93 vs 75 ±
7.11), PBF (34.69 ± 5.72 vs 29.12 ± 5.05) and BMI (27.51
± 5.37 vs 22.55 ± 2.9) in PCOS group were significantly
increased (P =0.000 for all comparisons), indicating that
these three parameters are valuable in facilitating the
screening or diagnosis of PCOS.
ROC curves of BMI, WC and PBF for diagnosing PCOS
The Rotterdam criteria was used as the gold standard
when to evaluate the accuracy of BMI, WC and PBF to
predict PCOS. Figure 2 is the ROC curve of the three
obesity parameters for diagnosing PCOS, Table 2 is the
area under the ROC curve of the three parameters for
diagnosing PCOS. The results in Table 2 show that in
general, the mean AUC for WC to diagnose PCOS is
0.814 with a standard error of 0.029 (P < 0.001 compared
with 0.5 which was set as a standard comparison for
AUC, please refer to the Statistical Analysis section); the
mean AUC for PBF to diagnose PCOS is 0.789 with a
standard error of 0.025 (P < 0.001 compared with 0.5 );
the mean AUC for BMI to diagnose PCOS is 0.782 with
a standard error of 0.028 (P < 0.001 compared with 0.5).
Each of the two groups was further divided into three
subgroups according to age: <26 y/o group, 26–31 y/o
group and >31 y/o group, and the data were further ana-
lyzed according to age groups. It was shown that the
AUCs of all the subgroups of the three obesity parame-
ters were all significantly larger than 0.5 (P <0.001).
Comparisons were also performed among the three pa-
rameters and there is no significant difference between
any of them, meaning that there is no better predictor
for PCOS among them.
The cut-off points and other features of the three obesity
parameters to diagnose PCOS
ROC curves as mentioned above was used to select the
best cut-off points of each of the three parameters to
diagnose PCOS. As mentioned in the Statistical Analysis
section, the best cut-off points for each of the three pa-
rameters to diagnose PCOS was determined based on
the maximum point of Youden index. In general, the
best cut-off point for WC to diagnose PCOS is 80.5 cm,
and at that point, its sensitivity to diagnose PCOS is
73.6 %, and specificity is 85.0 %; the best cut-off point
for PBF to diagnose PCOS is 29 %, and at that point, its
sensitivity to diagnose PCOS is 88.2 %, and specificity is
57.7 %; the best cut-off point for BMI to diagnose PCOS
is 26.6 kg/m2, and at that point, its sensitivity to diag-
nose PCOS is 54.5 %, specificity is 98.0 %. The results
are shown in Table 3. In the age subgroups, the trend is
similar: it seems that PBF has a better sensitivity and can
be used to screen PCOS, while BMI can be used in the
diagnosis of PCOS as it has a better specificity. The only
Table 1 Comparison of age, WC, PBF and BMI between control and PCOS groups
variables Statistical parameters Control group (n = 300) PCOS group (n = 110) P
Age (y/o) x  s 28.53 ± 3.26 28.55 ± 4.27 0.908
Median 28.5 (27,30) 28 (26,31)
Range (Max, Min) 15 (23,38) 24 (16,40)
WC (cm) x  s 75 ± 7.11 89.67 ± 13.93 0.000
Median 75 (67,79) 89 (80,100)
Range (Max, Min) 28 (64,92) 60 (64,124)
PBF (%) x  s 29.12 ± 5.05 34.69 ± 5.72 0.000
Median 28.58 (26,32) 34.19 (30.98,38.27)
Range (Max, Min) 40.1 (6.55,46.65) 31.32 (16.11,47.43)
BMI(kg/m2) x  s 22.55 ± 2.9 27.51 ± 5.37 0.000
Median 22.81 (20.39,24.01) 27.26 (23.36,31.61)
Range (Max, Min) 16.92 (17.46,34.37) 26.77 (17.46,44.23)
Max Maximum, Min Minimum; y/o years old
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exception is that in age subgroup of older than 31 y/o,
WC has a better sensitivity than PBF (81.3 % vs 71.9 %).
Discussion
Studies from different countries have shown that the
incidence rate of obesity in patients with PCOS was
30–70 % [3, 4]. Obese PCOS patients tend to have more
severe endocrinological, reproductive and metabolic disor-
ders (except hirsutism), manifested by increases of total
testosterone level, fasting glucose level, fasting insulin level,
insulin resistance and lipid lvel, and decrease of sex
hormone-binding globulin (SHBG) level [6]. The current
view of the main mechanism of PCOS is the accumulation
of excessive visceral fat tissue which causes insulin resist-
ance through secretion of factors such as leptin [7], adipo-
nectin, interleukin-6. This was followed by promotion of
androgen synthesis by theca cells and inhibition of hepatic
synthesis of SHBG, which together lead to increase of free
testosterone concentration in the blood , and subsequently
exacerbation of hyperandrogenism further [8]. In addition
to affecting women’s reproductive function and pregnancy
outcomes, the risk of metabolic syndrome, type 2 DM,
CVD and breast cancer, endometrial cancer and other
long-term complications in obese PCOS patients are also
exponentially increased [5]. The main causes of obesity in
PCOS patients are excessive daily intake of carbohydrate-
rich, high-glycemic and high saturated fat diet, and too
little exercise [9]. Mild weight loss in overweight or obese
PCOS patients (a decrease of 5–10 %) could lead to decline
in serum testosterone levels, also lead to return of normal
ovulation cycle, improve pregnancy success rate [10–13] ,
and improve hormone, glucose and lipid metabolism disor-
ders [14] and decrease the risk for CVD [15]. Therefore,
physicians should not only intervene against PCOS’ clinical
manifestations, but also should encourage weight loss in
these PCOS patients to decrease long-term metabolic risk.
There are many parameters in analyzing obesity, among
which, BMI, WC and PBF are the most widely used ones,
but with different focus: BMI focus on evaluation of human
density, WC focus on evaluation of human girth, PBF focus
Fig. 1 The percentage histogram of age, WC, PBF and BMI between PCOS and normal control groups
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on evaluation of body fat [16]. The accuracy of using these
three parameters to predict and diagnose obese PCOS still
need to be assessed. In the meantime, due to the difference
in race among different countries around the world, there
is difference in detection rate of obesity when different cut-
off points of obesity parameters were used, therefore, it is
necessary to study the cut-off points of BMI, WC and PBF
unique to Chinese women of child-bearing age with PCOS.
This study was based on the Rotterdam diagnosis criteria
for PCOS [17], where we analyzed the BMI, WC and PBF
of 300 women ofchild-bearing age with PCOS who visited
the Reproduction and Genetic Center in Peking University
Fig. 2 ROC curve of WC, PBF and BMI for the diagnosis of PCOS





AUC ± SE 95 % CI of AUC Somers’ D Pa P
Lower limit Upper limit
<26 WC (cm) 0.798 ± 0.068 0.665 0.930 0.596 <0.001 0.558b
PBF (%) 0.769 ± 0.060 0.650 0.887 0.537 <0.001 0.526c
BMI (kg/m2) 0.817 ± 0.059 0.701 0.933 0.634 <0.001 0.134d
26–31 WC (cm) 0.787 ± 0.0423 0.704 0.8700 0.574 <0.001 0.551b
PBF (%) 0.765 ± 0.0361 0.694 0.8355 0.529 <0.001 0.544c
BMI (kg/m2) 0.768 ± 0.0403 0.689 0.8472 0.537 <0.001 0.898d
>31 WC (cm) 0.889 ± 0.043 0.806 0.973 0.779 <0.001 0.001b
PBF (%) 0.838 ± 0.042 0.756 0.920 0.676 <0.001 0.090c
BMI (kg/m2) 0.773 ± 0.061 0.654 0.891 0.545 <0.001 0.138d
合计 WC (cm) 0.814 ± 0.029 0.758 0.870 0.629 <0.001 0.100b
PBF (%) 0.789 ± 0.025 0.7397 0.838 0.577 <0.001 0.261c
BMI (kg/m2) 0.782 ± 0.028 0.7265 0.838 0.564 <0.001 0.724d
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First Hospital from June 2015 to January 2016, as well as
110 cases of age-matched healthy women as normal con-
trol. We compared the sensitivity and specificity of the
three obesity parameters in diagnosing PCOS, trying to
provide evidence for reasonable use of obesity parameters
in facilitating the diagnosis of PCOS among high risk
population.
The results of this study showed that compared with
the healthy control group, all three parameters in PCOS
group, BMI, WC and PBF were significantly increased,
consistent with previous reports [18], indicating the
severity of overweight and obesity in patients with PCOS
which leads to exacerbation of endocrine and reproductive
metabolic disorders [19].
Our results also showed that, the AUC features of the
three obesity parameters were greater than 0.5. AUC
reflects the sensitivity and specificity of a certain index
in general in the diagnosis of diseases, and the overall
diagnostic accuracy of this indicator: 0.5 < AUC ≤ 0.7
means a low diagnostic accuracy, 0.7 < AUC ≤ 0.9 means
medium diagnostic accuracy, 0.9 < AUC <1.0 means a
high diagnostic accuracy [20]. This study demonstrated
that these three parameters are all valuable for predict-
ing obesity PCOS, and there was no significant differ-
ence among them. Previous studies show that, WC is
superior in the accuracy of BMI and other parameters in
predicting metabolic syndrome in China [21, 22], meta-
bolic syndrome in PCOS patients in South Korea [23]
and Brazil [24]. The reason, mainly is that obesity and
overweight are two different concepts. BMI represents
body mass and represents a proportional relationship
between weight and height, and it cannot reflect the
body fat content [25–28], and therefore it is not appro-
priate to use BMI alone to assess the degree of obesity.
WC is an indicator of central obesity and central obesity
is not correlated with human mass index, it mainly
refers to the accumulation of visceral fat, thus it is a
better predictor of risk of metabolic syndrome and car-
diovascular disease [29], and WC is the simplest method
of human body measurement. Results of this study sug-
gest that at the time of the census of PCOS among
childbearing women, it is recommended that the first
choice is WC measurement since it is simple and has
equal value in diagnosing PCOS.
Based on bioelectrical impedance principle, body com-
position analyzer can measure content of water in human
body, as well as calculate PBF. It is an accurate, noninvasive
and simple method to measure of the content and the
proportion of human body fat [30]. Previous studies have
shown that BMI showed high specificity and low sensitivity
in the diagnosis of obesity, pointing out that BMI missed
almost half of the obese population diagnosed by PBF
[31–33]. Recent studies have shown that even with
normal-weight, high PBF was also associated with insu-
lin resistance [34], PBF is a better indicator to predict
obesity [35], so more and more scholars began to study
the value of measurement of body composition in obes-
ity diagnosis [36–40]. The results of this study showed
the AUC of PBF is not significantly different from the
other two parameters, not consistent with previous
findings [41]. Nevertheless, this study suggests that in
the future, on the basis of PCOS sample, we can further
dig into the value of body fat percentage measured
using bioelectrical impedance method in the diagnosis
of PCOS.
World Health Organization (WHO) [42] and the Inter-
national Diabetes Federation (IDF) [43] have determined
the cut-off point of BMI and WC in diagnosing obesity
according to differences in the ethnic, race and morph-
ology: For Chinese adult, 24 kg/m2 ≤ BMI <28 kg/m2 is de-
fined as overweight, the BMI ≥ 28 kg/m2 is defined as
obese; or female waist ≥80 cm is defined as overweight or
central obesity; The normal range value of female PBF is
23 ± 5 % and PBF ≥ 30 % is defined as obese. Korean studies
Table 3 Cut-off points and other parameters of WC, PBF and BMI in diagnosis of PCOS
Age (y/o) Obesity parameter Cut-off point Sensitivity (%) Specificity (%) Youden index NPV (%) PPV (%)
<26 WC (cm) 93.5 56.5 100 0.565 69.7 100
PBF (%) 28.3 91.3 64.2 0.555 88.1 71.8
BMI (kg/m2) 26.6 56.5 100 0.565 69.7 100
26–31 WC (cm) 80.5 69.1 84.5 0.536 73.2 81.7
PBF (%) 29.9 85.5 60.9 0.464 80.8 68.6
BMI (kg/m2) 26.5 45.5 98.9 0.444 64.5 97.6
>31 WC (cm) 81.0 81.3 93.2 0.745 83.3 92.3
PBF (%) 33.0 71.9 83.6 0.555 74.8 81.4
BMI (kg/m2) 26.6 68.8 94.5 0.633 75.2 92.6
Total WC (cm) 80.5 73.6 85.0 0.586 76.3 83.1
PBF (%) 29.0 88.2 57.7 0.459 83.0 67.6
BMI (kg/m2) 26.6 54.5 98.0 0.525 68.3 96.5
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[23] showed that WC 80 cm was the best cut-off point for
the best prediction of PCOS in Korean women; Brazilian
studies [24] show WC 95 cm was the best cut-off point for
the best prediction of PCOS in Brazilian women. The re-
sults of this study confirmed that, BMI 26.6 kg/m2, WC
80.5 cm and PBF 29 %, were the best cut-off point for
diagnosing PCOS. The results of this study is similar to
the studies with South Korea, which may be related to
ethnic characteristics.
The results of this study also showed that, the three
obesity parameters have different sensitivity and specificity.
For example, whether in general or in age subgroups, BMI
always has the best specificity among the three. While with
only one exception in one age subgroup, PBF always has
the best sensitivity among the three. These results indicate
that, to screen for high-risk PCOS patients in Chinese
women of reproductive age, PBF is the first choice as it is
more sensitive, except in patients over 31 y/o, WC can be
used as an alternative. So the cut-off point of PBF at 29 %
can be used as reference standard for epidemiological
investigation and preliminary screening of PCOS in the
community, then the gold standard of Rotterdam criteria
was used for confirmatory diagnosis. In this case, not only
the risk factor of PCOS can be prevented earlier, but also
avoid causing excessive pressure to the public, it can also
adapt to the manpower burden in disease prevention and
control, is a reasonable strategy in saving health resources.
While in diagnosing PCOS, BMI has better value as it
is more specific. So the cut-off point of BMI at 26.6 kg/m2
can be used to facilitate the diagnosis of PCOS as it has a
specificity of 98 %. It can be used as a relatively reliable
diagnosis reference for PCOS when limited by equipment
or economic situation, i.e., no ultrasound or sex hormones
test available.
One disadvantage of this study is that the study subjects
enrolled in this study were all from northern China, in the
future, we still need to further expand the sample size, to
summarize population data from multiple regions in China,
and to establish a more accurate cut-off points in the pre-
diction, screening and diagnosis of PCOS, as well as to ad-
minister weight loss treatment in obese PCOS patients to
prevent long-term complications.
Conclusion
To summarize, endocrine, reproductive and metabolic
disorders are more severe in obese PCOS patients. BMI,
WC and PBF are three important parameters to measure
obesity. This study shows that patients with PCOS have
serious overweight or obesity problems. WC, PBF and
BMI are valuable in screening or diagnosing PCOS. PBF
has a better sensitivity and can be used to screen PCOS,
while BMI can be used in the diagnosis of PCOS as it
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